SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Outpatient Sites Become A Central Part of Care

HEALTH: Revenue Needs, Market Trends Push ChangeSan Diego hospitals in the last few years boosted investment in modest freestanding centers for surgery, imaging and other services, vying for patients seeking convenience and lower costs.

ResMed Revenue Surges 15 Percent in Q3

San Diego-based ResMed reported $591.6 million in third quarter revenue, a 15 percent year-over-year increase.

Acadia’s Stock Falls on FDA Reexamination

The U.S. Food and Drug Administration said it was reexamining San Diego-based Acadia Pharmaceuticals’ drug to treat hallucinations and delusions caused by Parkinson’s disease. The news was first reported by CNN on April 25.

Illumina’s Revenue Increase Tops Analysts’ Expectations

Illumina reported $782 million in first quarter revenue, a 31 percent year-over-year increase, the company announced April 24.

Dthera Sciences Appoints Steve Martin to Board

Steve Martin, a seasoned CFO, has joined Dthera Sciences’ board.

Skaggs School Launches Masters Degree for Drug Development, Management

UC San Diego’s Skaggs School of Pharmacy and Pharmaceutical Sciences has launched a master of science in drug development and product management, a first-of-its-kind offering.

Orexigen Agrees to Sell Its Assets to Nalpropion for $75M

Orexigen agrees to sell its assets.

Ionis Inks $1 Billion Deal with Biogen

Biogen will pay Carlsbad’s Ionis Pharmaceuticals $1 billion in cash as part of a 10-year collaboration around neurological drug development.

ResMed’s CEO Eyes Greater Market Share

BIOTECH: Software Success To Move On to Analytics, AI

Five years ago, Michael “Mick” Farrell listened to an analyst forecast ResMed’s demise.

Tease photo

Tocagen Licenses Its Immunotherapy in China

Citing regulatory changes, San Diego’s Tocagen licensed its immunotherapy for commercialization in China, earning the company $16 million upfront and potentially much more.

French Company Acquires Astute Medical for $90 Million

French diagnostics giant bioMérieux acquired San Diego-based Astute Medical in a $90 million cash deal announced earlier this month.

Grossmont Clinic for Non-Emergency Conditions Opens

Sharp Grossmont Hospital has opened a new clinic, which looks to reduce patient volumes in the hospital’s emergency room, one of the busiest in San Diego County.

Irwin Jacobs, Martin Wygod Join Biological Dynamics Board

Biological Dynamics, a San Diego cancer diagnostics company, named Irwin Jacobs and Martin Wygod to its board, it was announced April 13.

Human Longevity, Inc. Teams with Nonprofit for Pilot Program

The company said the pilot program will put up to 100 San Diego Fire-Rescue Department firefighters and 10 alternates through screening, including genome sequencing.

Tandem Diabetes Care Continues Momentum in Preliminary Q1 Results

Tandem Diabetes Care reported a 42 percent year-over-year increase in preliminary quarter one sales, increasing the company’s stock.

Prev